APOTHEEK SYNAPS PARK
ActiveAPOTHEEK SYNAPS PARK has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €170k and a net result of €48k. Equity is growing by ~28.2% per year across the filed fiscal years. Its solvency ranks better than 95% of 10310 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Checked score
Score 2025
92
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.7%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €15k at 30 days acceptable
Liquidity ample (current ratio 12.24 against 18.21 in 2024; short-term debt: 7.7% and cash: 34.6% of total assets), and 10.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
89.8%
Return on assets
25.1%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-08-2026, 14 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 8 filingsDeviation from the deadline
2025
14 d late
2024
27 d late
2023
26 d late
2022
30 d late
2021
26 d late
2020
24 d late
2019
39 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€170k▲ 38.8%
2024 · €123k
2018: €24k
2019: €41k
2020: €106k
2021: €53k
2022: €43k
2023: €75k
2024: €123k
2018 → 2025
Total assets
€190k▲ 43.9%
2024 · €132k
2018: €69k
2019: €67k
2020: €189k
2021: €117k
2022: €106k
2023: €115k
2024: €132k
2018 → 2025
Net result
€48k▼ 1.0%
2024 · €48k
2018: €12k
2019: €16k
2020: €-45k
2021: €-53k
2022: €-10k
2023: €31k
2024: €48k
2018 → 2025
Working capital
€163k▲ 49.0%
2024 · €110k
2018: €15k
2019: €34k
2020: €127k
2021: €24k
2022: €50k
2023: €64k
2024: €110k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€53k-€43k▼ 18.7%€75k▲ 72.4%€123k▲ 64.3%€170k▲ 38.8%
Operating result€-51k-€-9k▲ 82.1%€33k€51k▲ 53.5%€58k▲ 14.5%
Net result€-53k-€-10k▲ 81.2%€31k€48k▲ 53.2%€48k▼ 1.0%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen four years in a row; 2025 is 15% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €190k
Fixed assets
€12k▼ 25.7%
Current assets
€178k▲ 53.4%
Equity and liabilities €190k
Equity
€170k▲ 38.8%
Debt
€19k▲ 113%
The debt ratio rises from 6.9% to 10.2%. Equity and debt are higher.
Key figures and ratios
EBITDA
€62k▲
2024 · €55k
Cash flow
€52k▼
2024 · €52k
Solvency
89.8%▼
2024 · 93.1%
Current ratio
12.24▼
2024 · 18.21
Quick ratio
6.14▼
2024 · 8.87
Debt / equity
0.11▲
2024 · 0.07
ROE
27.9%▼
2024 · 39.1%
ROA
25.1%▼
2024 · 36.4%
Interest coverage
22.90▲
2024 · 13.80
Debt
€19k▲
2024 · €9k
Debt ≤ 1 year
€15k▲
2024 · €6k
Income taxes
€9k
Staff costs
€82k▲
2024 · €77k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€132k€190k▲
Fixed assets21/28€16k€12k▼
Tangible fixed assets22/27€16k€12k▼
Plant, machinery and equipment23€3k€2k▼
Furniture and vehicles24€13k€10k▼
Current assets29/58€116k€178k▲
Stocks and contracts in progress3€59k€89k▲
Stocks30/36€59k€89k▲
Amounts receivable within one year40/41€15k€18k▲
Trade receivables40€15k€18k▲
Other amounts receivable41€3€3=
Cash at bank and in hand54/58€37k€66k▲
Deferred charges and accrued income490/1€4k€6k▲
Equity and liabilities
Total equity and liabilities10/49€132k€190k▲
Equity10/15€123k€170k▲
Contributions10/11€122k€122k=
Reserves13€28k€48k▲
Distributable reserves133€28k€48k▲
Profit (loss) carried forward14€-28k€0▲
Amounts payable17/49€9k€19k▲
Amounts payable within one year42/48€6k€15k▲
Current portion of amounts payable after more than one year42€0-
Trade debts44€271€5k▲
Suppliers440/4€271€5k▲
Taxes, remuneration and social security45€6k€9k▲
Taxes450/3€5k€8k▲
Remuneration and social security454/9€1k€900▼
Accrued charges and deferred income492/3€3k€5k▲
Income statement
Code20242025
Remuneration, social security and pensions62€77k€82k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4k€4k▼
Other operating charges640/8€1k€283▼
Gross operating margin9900€133k€144k▲
Operating profit (loss)9901€51k€58k▲
Financial income75/76B€1k€932▼
Recurring financial income75€1k€932▼
Financial charges65/66B€4k€3k▼
Recurring financial charges65€4k€3k▼
Profit (loss) for the period before taxes9903€48k€56k▲
Income taxes67/77-€9k
Profit (loss) for the period9904€48k€48k▼
Profit (loss) for the period to be appropriated9905€48k€48k▼
Appropriation of the result
Profit (loss) to be appropriated9906€-28k€19k▲
Profit (loss) brought forward from the previous period14P€-76k€-28k▲
Transfer to equity691/2-€19k
To other reserves6921-€19k
Social balance
Average headcount (FTE)90871.01.0=
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
14-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 14 days late
2025
31-12
Financial
Equity above €150kEq €170k ▲38.8%
3 profitable years in a row build equity to €170k.
27-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 27 days late
2024
31-12
Financial
Highest result since 2018net €48k ▲53.2%
Net result €48k, the highest in the series.
31-12
Financial
Liquidity times 6current ratio 18.21
Current ratio from 3.07 to 18.21; short-term debt falls from €31k to €6k.
31-12
Financial
Equity above €100kEq €123k ▲64.3%
2 profitable years in a row build equity to €123k.
26-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 26 days late
2023
31-12
Financial
Back to profitnet €31k
Net result €31k after 3 loss-making years.
30-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 30 days late
2022
26-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 26 days late
2021
31-12
Financial
Weakest financial yearnet €-53k
Net result drops to €-53k, the lowest in the series; recovery starts the following year.
24-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 24 days late
2020
31-12
Financial
Liquidity triplescurrent ratio 6.52
Current ratio from 2.36 to 6.52; short-term debt falls from €25k to €23k.
31-12
Financial
Equity above €100kEq €106k ▲161%
Equity rises from €41k to €106k.
08-09
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 39 days late
2019
23-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 23 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Genk · 1 establishment unit since 2017
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Synaps Park 11903600 GenkGround area
16.0 ha
Building footprint
3.6 ha
Parcel 71016I1216/00S000, Flanders. Linked by address, not a title deed.
1 establishment unit
APOTHEEK KEMPENEERS
since 20172.269.424.767
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71016I1216/00S000 | Flanders | 16.0 ha | 1 · 3.6 ha | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteGenk2.269.424.767
Similar companies · same sector, comparable size
FARMA V.T.B.
BE 0446.285.023
Oud-Turnhout · Eq €170k
Apotheek D'HEER Pharma
BE 0446.071.227
Lokeren · Eq €170k
ELAPHARMA
BE 0785.990.208
Brussel · Eq €170k
APOTHEEK DE REIGER
BE 0425.748.440
Kontich · Eq €170k
PHARMACIE EVRARD - NORTIER
BE 0464.369.880
Charleroi · Eq €170k
Of 5,223 companies in sector 47730 we hold annual accounts for 3,862. 3,574 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded31-10-2017
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.